New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
| The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04B DOPAMINERGIC AGENTS
N04BX Other dopaminergic agents
This group comprises dopaminergic agents which cannot be classified in the preceding groups.
The combination of levodopa, decarboxylase inhibitor and COMT inhibitor is classified in N04BA - Dopa and dopa derivatives.
| ATC code | Name | DDD | U | Adm.R | Note |
| N04BX02 | entacapone | 1 | g | O |
Last updated: 2024-01-26